Attached files
| file | filename |
|---|---|
| 10-K/A - AMENDMENT NO. 1 TO FORM 10K - Augmedix, Inc. | f10k2020a1_augmedixinc.htm |
| EX-32.1 - CERTIFICATION - Augmedix, Inc. | f10k2020a1ex32-1_augmedix.htm |
| EX-31.2 - CERTIFICATION - Augmedix, Inc. | f10k2020a1ex31-2_augmedix.htm |
| EX-31.1 - CERTIFICATION - Augmedix, Inc. | f10k2020a1ex31-1_augmedix.htm |
| EX-23.1 - CONSENT OF FRANK, RIMERMAN + CO. LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING F - Augmedix, Inc. | f10k2020a1ex23-1_augmedix.htm |
Exhibit 32.2
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with this Annual Report of Augmedix, Inc. (the “Company”) on Form 10-K/A for the period ending December 31, 2020 (the “Report”), I certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:
| (1) | The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
| (2) | The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company. |
| Date: June 30, 2021 | By: | /s/ Paul Ginocchio |
| Paul Ginocchio | ||
| Chief
Financial Officer (Principal Financial Officer and Principal Accounting Officer) |